docling/tests/data/groundtruth/docling_v2/10-1055-s-0044-1786808.nxml.itxt

item-0 at level 0: unspecified: group _root_
  item-1 at level 1: title: Proposal and Validation of a Cli ... ulation Diagnostic Criteria for Sepsis
  item-2 at level 1: paragraph: Kazuma Yamakawa; Department of E ... hi Tokushukai Hospital, Sapporo, Japan
  item-3 at level 1: text: Background Japanese Association  ... native criteria for sepsis management.
  item-4 at level 1: section_header: Introduction
    item-5 at level 2: text: Disseminated intravascular coagu ...  are widely used in clinical settings.
    item-6 at level 2: text: The JAAM DIC criteria have sever ... sis, this burden should be eliminated.
  item-7 at level 1: section_header: Study Population
    item-8 at level 2: text: This investigation was performed ... ., SOFA score of 2 or more points). 13
  item-9 at level 1: section_header: Data Collection and Definitions
    item-10 at level 2: text: A case report form was developed ... e was all-cause in-hospital mortality.
  item-11 at level 1: section_header: Newly Proposed Modified JAAM-2 DIC Criteria
    item-12 at level 2: text: We proposed novel DIC criteria n ... s set at 3 points or more ( Table 2 ).
  item-13 at level 1: section_header: Statistical Analysis
    item-14 at level 2: text: The overall effectiveness of ant ...  along with estimated survival curves.
  item-15 at level 1: section_header: Patient Characteristics
    item-16 at level 2: text: The patient flow diagram is show ... CU registry in the final study cohort.
    item-17 at level 2: text: Baseline characteristics of the  ...  the anticoagulant and control groups.
  item-18 at level 1: section_header: Prognostic Value of the Criteria
    item-19 at level 2: text: ROC curves for the original JAAM ... teria was considered to be equivalent.
  item-20 at level 1: section_header: Validity of the Criteria in Initiating Anticoagulation
    item-21 at level 2: text: Survival curves for the anticoag ... g DIC was considered to be equivalent.
  item-22 at level 1: section_header: Clinical Application of the Findings
    item-23 at level 2: text: Several different clinical pract ... tion and determining treatment timing.
    item-24 at level 2: text: Modification of the JAAM DIC cri ...  a totally clinical-friendly approach.
    item-25 at level 2: text: We intended to evaluate the seve ... 24 proposed by the ISTH in the future.
  item-26 at level 1: section_header: Strengths and Limitations
    item-27 at level 2: text: We acknowledge several limitatio ... tis should be conducted in the future.
  item-28 at level 1: section_header: Tables
  item-30 at level 1: table with [22x2]
    item-30 at level 2: caption: Table 1 Underlying diseases targeted by the JAAM-2 DIC criteria
  item-32 at level 1: table with [38x4]
    item-32 at level 2: caption: Table 3 Baseline characteristics of included sepsis patients in the three datasets
  item-33 at level 1: section_header: Figures
  item-35 at level 1: picture
    item-35 at level 2: caption: Fig. 1 Patient flow for the three datasets used in this study. DIC, disseminated intravascular coagulation; JAAM, Japanese Association for Acute Medicine; ROC, receiver operating characteristic.
  item-37 at level 1: picture
    item-37 at level 2: caption: Fig. 2 Receiver operating characteristic curves for original JAAM and modified JAAM-2 DIC criteria as predictors of in-hospital mortality. The solid line represents curves for JAAM-2, and the dotted line represents curves for original JAAM. (A) J-Septic DIC dataset, (B) FORECAST dataset, (C) SPICE dataset. DIC, disseminated intravascular coagulation; JAAM, Japanese Association for Acute Medicine.
  item-39 at level 1: picture
    item-39 at level 2: caption: Fig. 3 Adjusted estimated survival curves according to the original JAAM and modified JAAM-2 DIC status using the J-septic DIC dataset. (A) JAAM DIC score ≤ 3, (B) JAAM DIC score ≥ 4, (C) JAAM-2 DIC score ≤ 2, and (D) JAAM-2 DIC score ≥ 3. The solid line represents patients in the anticoagulant group, and the dotted line represents patients in the control group. DIC, disseminated intravascular coagulation; JAAM, Japanese Association for Acute Medicine.
  item-41 at level 1: picture
    item-41 at level 2: caption: Fig. 4 Adjusted estimated survival curves according to the original JAAM and modified JAAM-2 DIC status using the FORECAST dataset. (A) JAAM DIC score ≤ 3, (B) JAAM DIC score ≥ 4, (C) JAAM-2 DIC score ≤ 2, and (D) JAAM-2 DIC score ≥ 3. The solid line represents patients in the anticoagulant group, and the dotted line represents patients in the control group. DIC, disseminated intravascular coagulation; JAAM, Japanese Association for Acute Medicine.
  item-42 at level 1: section_header: References
  item-43 at level 1: list: group list
    item-44 at level 2: list_item: M Levi; H Ten Cate. Disseminated ... cular coagulation. N Engl J Med (1999)
    item-45 at level 2: list_item: M Hayakawa; S Saito; S Uchino. C ... ing 2011-2013. J Intensive Care (2016)
    item-46 at level 2: list_item: S Gando; A Shiraishi; K Yamakawa ... on in severe sepsis. Thromb Res (2019)
    item-47 at level 2: list_item: N Kobayashi; T Maekawa; M Takada ...  on DIC in Japan. Bibl Haematol (1983)
    item-48 at level 2: list_item: F B Taylor; C H Toh; W K Hoots;  ... lar coagulation. Thromb Haemost (2001)
    item-49 at level 2: list_item: T Iba; Y Umemura; E Watanabe; T  ... nd coagulopathy. Acute Med Surg (2019)
    item-50 at level 2: list_item: K Yamakawa; J Yoshimura; T Ito;  ... pathy in sepsis. Thromb Haemost (2019)
    item-51 at level 2: list_item: S Gando; T Iba; Y Eguchi. A mult ... current criteria. Crit Care Med (2006)
    item-52 at level 2: list_item: S Gando; D Saitoh; H Ogura. Natu ... ospective survey. Crit Care Med (2008)
    item-53 at level 2: list_item: H Ogura; S Gando; T Iba. SIRS-as ... ts with thrombocytopenia. Shock (2007)
    item-54 at level 2: list_item: . American College of Chest Phys ... rapies in sepsis. Crit Care Med (1992)
    item-55 at level 2: list_item: K M Kaukonen; M Bailey; D Pilche ... ing severe sepsis. N Engl J Med (2015)
    item-56 at level 2: list_item: M Singer; C S Deutschman; C W Se ... d Septic Shock (Sepsis-3). JAMA (2016)
    item-57 at level 2: list_item: T Abe; H Ogura; A Shiraishi. Cha ... : the FORECAST study. Crit Care (2018)
    item-58 at level 2: list_item: T Abe; K Yamakawa; H Ogura. Epid ... m (SPICE-ICU). J Intensive Care (2020)
    item-59 at level 2: list_item: R C Bone; R A Balk; F B Cerra. D ... tive therapies in sepsis. Chest (1992)
    item-60 at level 2: list_item: J L Vincent; R Moreno; J Takala. ... re Medicine. Intensive Care Med (1996)
    item-61 at level 2: list_item: M Levi; C H Toh; J Thachil; H G  ... ular coagulation. Br J Haematol (2009)
    item-62 at level 2: list_item: H Wada; H Asakura; K Okamoto. Ex ... oagulation in Japan. Thromb Res (2010)
    item-63 at level 2: list_item: M Di Nisio; F Baudo; B Cosmi. Di ...  Thrombosis (SISET). Thromb Res (2012)
    item-64 at level 2: list_item: H Wada; J Thachil; M Di Nisio. G ... ee guidelines. J Thromb Haemost (2013)
    item-65 at level 2: list_item: Y Umemura; K Yamakawa; T Kiguchi ... iteria. Clin Appl Thromb Hemost (2016)
    item-66 at level 2: list_item: T Iba; M Di Nisio; J Thachil. Re ... ntithrombin activity. Crit Care (2016)
    item-67 at level 2: list_item: T Iba; M D Nisio; J H Levy; N Ki ... f a nationwide survey. BMJ Open (2017)
    item-68 at level 2: list_item: S Kushimoto; S Gando; D Saitoh.  ... psis and trauma. Thromb Haemost (2008)
    item-69 at level 2: list_item: A Sawamura; M Hayakawa; S Gando. ... rly phase of trauma. Thromb Res (2009)
    item-70 at level 2: list_item: K Iwai; S Uchino; A Endo; K Sait ... ute Medicine (JAAM). Thromb Res (2010)
    item-71 at level 2: list_item: T Takemitsu; H Wada; T Hatada. P ... lar coagulation. Thromb Haemost (2011)